×
Breaking News
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA | Patients May See Improved Outcomes with Ravulizumab
JUST RELEASED | 5th Edition of TIF’s Guidelines for the Management of Transfusion Dependent β-Thalassaemia
TIF AI KNOWLEDGE BOT | Your Go-To Source for Thalassaemia Information
EDUCATIONAL WEBINAR ON HEART COMPLICATIONS IN HAEMOGLOBINOPATHIES | 30 January 2025
HEALTH TECHNOLOGY ASSESSMENT | EU Implements New Rules to Offer Quicker Access to Advanced Medicines
TIF CARE | A New Era in Healthcare Collaboration
TIF READINESS ASSESSMENT TOOL | Is Your Country Ready for Advanced Thalassaemia Therapies?
WEBINAR | New Advances in the Prevention of Thalassaemia: Potential for High-Prevalence Regions
NEW FACTSHEET | The Advanced Therapy Medicinal Products (ATMPs) Labyrinth
POSITION PAPER | The Views of TIF on Advanced Therapy Medicinal Products (ATMPs)
English
English
Ελληνικά
Français
Deutsch
Italiano
العربية
Menu
Home
Who we are
TIF History
Vision & Mission
Pillars of Work
Board of Directors
Staff Members
TIF Members
Collaborations
Transparency
Awards & Honours
What we do
Education
Country Work
Projects
Global Thalassaemia Review
COVID-19 Pandemic
Surveys
Haemoglobin Disorders
Thalassaemia
Sickle Cell Disease
Clinical Trial Updates
Positions & Policies
Policy Framework
Position Papers
Official Statements
Publications
TIF Publications
Scientific Literature
Additional Resources
Media Centre
News
Newsletters
Events
Videos
Contact us
Search for
Nothing Found
It seems we can’t find what you’re looking for. Perhaps searching can help.
Search for:
Back to top button
Close
Search for